Insider filing · PHVS
Robert Glassman
Director
profile →
Pharvaris N.V.
PHVS · Healthcare · 30 filings in 24 months
ticker →
Robert Glassman sold $298K of Pharvaris (PHVS)
Executed May 15, disclosed May 19, 4 days later.
Value, as filed
$298K
10,000 sh across 2 lots
Executed
May 15
the trade date, as filed
Disclosed
May 19
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RGRobert Glassman (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Pharvaris N.V. (PHVS). The largest single filing was $559K of PHVS (14,493 sh × $38.56, as filed), executed Sep 17.
The name
PHVSHealthcare · Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases wit…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Robert Glassman in PHVS
PHVSSALE
Pharvaris N.V.
$559K14,493 sh × $38.56
Exec Sep 17
Filed Sep 21 · 3:16 PM ET PHVSSALE Pharvaris N.V. $332K
8,667 sh × $38.27
Exec Sep 15
Filed Sep 17 · 9:18 AM ET PHVSSALE Pharvaris N.V. $300K
8,000 sh × $37.55
Exec Sep 9
Filed Sep 11 · 12:25 PM ET